Page last updated: 2024-11-03

propafenone and Hypoplastic Left Heart Syndrome

propafenone has been researched along with Hypoplastic Left Heart Syndrome in 1 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Hypoplastic Left Heart Syndrome: A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.

Research Excerpts

ExcerptRelevanceReference
"Oral propafenone was administered and within 6 hours no further arrhythmias or side effects were noted."5.30Atrial flutter in a pediatric patient in the immediate period after the Fontan procedure: control with oral propafenone. ( Herzberg, GZ; Rossi, AF, 1997)
"Oral propafenone was administered and within 6 hours no further arrhythmias or side effects were noted."1.30Atrial flutter in a pediatric patient in the immediate period after the Fontan procedure: control with oral propafenone. ( Herzberg, GZ; Rossi, AF, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herzberg, GZ1
Rossi, AF1

Other Studies

1 other study available for propafenone and Hypoplastic Left Heart Syndrome

ArticleYear
Atrial flutter in a pediatric patient in the immediate period after the Fontan procedure: control with oral propafenone.
    Pacing and clinical electrophysiology : PACE, 1997, Volume: 20, Issue:12 Pt 1

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Flutter; Child, Preschool; Electrocardiography;

1997